Next Article in Journal
Mapping and Validation of Peptides Differentially Recognized by Antibodies from the Serum of Yellow Fever Virus-Infected or 17DD-Vaccinated Patients
Next Article in Special Issue
Cellular Lipids—Hijacked Victims of Viruses
Previous Article in Journal
Myocardial Infarction Following COVID-19 Vaccine Administration: Post Hoc, Ergo Propter Hoc?
Previous Article in Special Issue
History of the Wastewater Assessment of Polio and Non-Polio Enteroviruses in the Slovak Republic in 1963–2019
 
 
Article
Peer-Review Record

Vaccination, Risk Factors and Outcomes of COVID-19 Infection in Patients with Psoriasis—A Single Centre Real-Life Experience from Eastern Slovakia

Viruses 2022, 14(8), 1646; https://doi.org/10.3390/v14081646
by Janette Baloghová 1,2,*, Tomáš Kampe 2, Peter Kolarčik 3,4 and Elena Hatalová 5
Reviewer 2:
Viruses 2022, 14(8), 1646; https://doi.org/10.3390/v14081646
Submission received: 28 June 2022 / Revised: 22 July 2022 / Accepted: 25 July 2022 / Published: 27 July 2022
(This article belongs to the Special Issue State-of-the-Art Virology Research in Slovakia)

Round 1

Reviewer 1 Report

The paper is acceptable for publication

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 2 Report

The manuscript by Baloghová et al. reported an interesting study to identify factors associated with contracting COVID-19 and determining the severity of COVID-19 among psoriatic patients in a real practice setting. They found the protective effect of vaccination, especially the third-dose, against the COVID-19 outcome. The results are interesting and would have significant impact on the COVID-19 research. Therefore, I would recommend its acceptance for publication after minor revision.

1) Plasma concentrations of proinflammatory molecules in patients with SARS‐CoV‐2 were discussed, but no positive conclusions were obtained. I would suggest to summarize there factors with some representative papers.

2)  Factors associated with vaccination status were discussed, however more informations related to the types of vaccination should be added.

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Back to TopTop